Novadip Biosciences Company

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.
Technology:
Stem cell therapy
Industry:
BioEngineering, Private
Headquarters:
Mont-saint-guibert, Brabant Wallon, Belgium
Founded Date:
2013-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
12
Total Funding:
87000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-11-03
Last Funding Type:
Series B
Register and Claim Ownership